A brief symptom index for advanced renal cell carcinoma

Keyphrases

• Symptom Score 100%
• Advanced Renal Cell Carcinoma (aRCC) 100%
• Patient-reported Outcomes 66%
• Biological Response Modifiers 66%
• Minimal Clinically Important Difference 66%
• Clinical Trials 33%
• Renal Cell Carcinoma 33%
• Nausea 33%
• Secondary Data Analysis 33%
• Metastatic Renal Cell Carcinoma (mRCC) 33%
• Phase I Trial 33%
• 3-point 33%
• Medical Experts 33%
• Index Score 33%
• High-score 33%
• Status number 33%
• Karnofsky Performance Status 33%
• Patient-reported Symptoms 33%
• Clinical Observational Study 33%
• Number of Metastatic Sites 33%
• Anchoring Mechanism 33%
• Baseline Scores 33%
• Sickness 33%
• Difference Estimate 33%
• Distribution-based Methods 33%
• Metastatic Risk 33%
• Mean Index 33%
• Internal Consistency Reliability 33%

Medicine and Dentistry

• Clear Cell Renal Cell Carcinoma 100%
• Clinical Trial 50%
• Biological Response Modifier 50%
• Diseases 50%
• Patient-Reported Outcome 50%
• Weakness 25%
• High Risk Population 25%
• Observational Study 25%
• Secondary Data 25%
• Nausea 25%
• Karnofsky Performance Status 25%
• Kidney Metastasis 25%

Nursing and Health Professions

• Renal Cell Carcinoma 100%
• Patient-Reported Outcome 50%
• Biological Response Modifier 50%
• Diseases 50%
• Clinical Trial 50%
• High Risk Population 25%
• Weakness 25%
• Nausea 25%
• Karnofsky Performance Status 25%
• Kidney Metastasis 25%
• Data Processing 25%